These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31475870)

  • 21. Drug development process and COVID-19 pandemic: Flourishing era of outsourcing.
    Wasan H; Singh D; Reeta KH; Gupta P; Gupta YK
    Indian J Pharmacol; 2022; 54(5):364-372. PubMed ID: 36537406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization.
    DeCorte BL
    J Med Chem; 2020 Oct; 63(20):11362-11367. PubMed ID: 32479727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk-Based Monitoring: Key Conditions in Collaboration Between Contract Research Organization and Sponsor.
    Wolfs M; Bambic A; Lange BS; Galante K; Plaza RS; O'Conallain C; Racaro G; Giblin M; Djali S
    Ther Innov Regul Sci; 2019 Jul; 53(4):512-518. PubMed ID: 30157695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost versus control: Understanding ownership through outsourcing in hospitals.
    Dalton CM; Warren PL
    J Health Econ; 2016 Jul; 48():1-15. PubMed ID: 27038997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Making the most of outsourcing relationships.
    Craig C
    Patient Acc; 1999 Oct; 22(10):2-3. PubMed ID: 10621470
    [No Abstract]   [Full Text] [Related]  

  • 26. Outsourcing in public health: a case study of contract failure and its aftermath.
    Young S
    J Health Organ Manag; 2008; 22(5):446-64. PubMed ID: 18959298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taking the pulse of strategic outsourcing relationships.
    Getz KA; Lamberti MJ; Kaitin KI
    Clin Ther; 2014 Oct; 36(10):1349-55. PubMed ID: 25444564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutting medical transcription costs.
    Forsman JA
    Healthc Financ Manage; 2003 Jul; 57(7):64-8. PubMed ID: 12866157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolution of the Pharma-CRO working relationship: AstraZeneca and Covance.
    Bioanalysis; 2017 Aug; 9(15):1171-1174. PubMed ID: 28795581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teleradiological outsourcing-compromises and hidden costs.
    Brady AP; Becker CD
    Eur Radiol; 2019 Apr; 29(4):1647-1648. PubMed ID: 30762110
    [No Abstract]   [Full Text] [Related]  

  • 31. Springhill Medical Center finds IT outsourcing formula.
    Sucher R
    J Healthc Inf Manag; 2003; 17(2):42-6. PubMed ID: 12698912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outsourcing satisfaction gives system a boost.
    Healthc Benchmarks; 2001 Feb; 8(2):20-2, 14. PubMed ID: 11272306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outsourcing bioanalytical services at Janssen Research and Development: the sequel anno 2017.
    Dillen L; Verhaeghe T
    Bioanalysis; 2017 Aug; 9(15):1195-1201. PubMed ID: 28762758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revenue cycle outsourcing: the real costs and benefits.
    Stockamp DR
    Healthc Financ Manage; 2006 Apr; 60(4):84-6, 88, 90. PubMed ID: 16610433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concerns and hopes about outsourcing decisions regarding health information management services at two teaching hospitals in Semnan, Iran.
    Kahouei M; Farrokhi M; Abadi ZN; Karimi A
    Health Inf Manag; 2016 Apr; 45(1):36-44. PubMed ID: 28691564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outsourcing in public hospitals: a Greek perspective.
    Moschuris SJ; Kondylis MN
    J Health Organ Manag; 2006; 20(1):4-14. PubMed ID: 16703840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model.
    Abberley L
    Bioanalysis; 2017 Aug; 9(15):1139-1144. PubMed ID: 28762760
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessing uncertainty in outsourcing clinical services at tertiary health centers.
    Billi JE; Pai CW; Spahlinger DA
    Int J Health Plann Manage; 2007; 22(3):245-53. PubMed ID: 17624877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conference report: a hitchhiker's guide to outsourcing ADME studies: the inside of outsourcing.
    Pritchard JF; Anderson SR; Breuckner C; Premkumar ND; Polli JW
    Bioanalysis; 2013 Feb; 5(4):403-5. PubMed ID: 23414372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.